RAB32 and glioblastoma: We also evaluated the protein levels of Rab32 in a series of clinical specimens, which included 31 glioma tissues (21 cases of GBM and 10 cases of grade 2–3) and 4 normal peri-tumor tissues, by both immunohistochemistry and western blot analysis.